As part of our submission review, we do have guidelines that outline the technical requirements a new drug would have to meet in order to be licensed in Canada. Companies must conduct studies to meet those standards, and those are reviewed and assessed by the veterinarians at Health Canada.
So that is guidance in the human safety department. Then based on their risk analysis, they will also schedule drugs. So you have schedule F, part I drugs, similar to what is on the human side, which are prescription--